PT PYRIDAM FARMA TBK |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 111 IDR | -2.63% |
|
0.00% | -90.31% |
| 10/05 | Foreign Investment Review Board Clears Probiotec Acquisition by Pyridam Farma | MT |
| 15/03 | PT Pyridam Farma Tbk Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 76.11M | - | - | - | - | - | |
| 816B | ||||||
| 634B | ||||||
| 351B | - | - | - | - | ||
| 323B | ||||||
| 293B |
